9001 Aerial Center Parkway
About Arrivo BioVenturesArrivo BioVentures, LLC is a privately held biopharmaceutical development company focused on identifying biologics and small molecules to improve patient care. Arrivo is based in Morrisville, N.C., on the edge of Research Triangle Park.
CEO: Stephen E. Butt
CBO: Michael F. Achermann
CFO: Karen Adams
5 articles about Arrivo BioVentures
Arrivo BioVentures today announced the closing of an oversubscribed Series B preferred financing round, totaling $100M.
Arrivo BioVentures announced today that the company has closed enrollment of a phase 2 clinical study with its most advanced program, SP-624, after having enrolled more than 300 patients with major depressive disorder.
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.